Literature DB >> 15965299

Seroprevalence to the circumsporozoite protein peptide antigen of Plasmodium vivax in Korean children.

Chae Seung Lim1, Jae Kyun Yoon, Eun Ah Chang, In Bum Suh, Seong Soo A An, Kee-Hyoung Lee, Ji Tae Chung, Young Chang Tockgo.   

Abstract

Recently, malaria re-emerged in the Republic of Korea (ROK), but there have been only a few reports on malaria seroprevalence. For the epidemiological study in children, a total of 1,176 serum samples were obtained from children and adolescent inhabitants from the three different regions, Pajoo, the Guro district in the western part of Seoul (Guro), and Ansan, from June to September 2002, when the transmission rate was high. Anti-circumsporozoite protein (CSP) antibody levels were assessed in samples using an indirect enzyme-linked immunosorbent assay (ELISA) method. Among the three regions, the highest IgG seroreactivity against the CSP antigen of Plasmodium vivax was found in the children from Pajoo (8.0%), followed by the children from Guro (3.2%), and those in Ansan (0.02%) had the lowest seroreactivity. In Pajoo, the profile of antibody response showed the highest in age 9, but decreased with age towards 12 years old. We found significant correlation between the seroprevalence and annual incidence in the investigated areas, suggesting that the area-related patterns reflected the differences of inoculation rates in children.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15965299     DOI: 10.1111/j.1348-0421.2005.tb03757.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  5 in total

1.  Anti-MSP-10 IgG indicates recent exposure to Plasmodium vivax infection in the Peruvian Amazon.

Authors:  Angel Rosas-Aguirre; Kailash P Patra; Maritza Calderón; Katherine Torres; Dionicia Gamboa; Edith Arocutipa; Edith Málaga; Katherine Garro; Carlos Fernández; Grace Trompeter; Yossef Alnasser; Alejandro Llanos-Cuentas; Robert H Gilman; Joseph M Vinetz
Journal:  JCI Insight       Date:  2020-01-16

2.  Plasmodium vivax sub-patent infections after radical treatment are common in Peruvian patients: results of a 1-year prospective cohort study.

Authors:  Peter Van den Eede; Veronica E Soto-Calle; Christopher Delgado; Dionicia Gamboa; Tanilu Grande; Hugo Rodriguez; Alejandro Llanos-Cuentas; Jozef Anné; Umberto D'Alessandro; Annette Erhart
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

3.  Serological markers for monitoring historical changes in malaria transmission intensity in a highly endemic region of Western Kenya, 1994-2009.

Authors:  Jacklyn Wong; Mary J Hamel; Chris J Drakeley; Simon Kariuki; Ya Ping Shi; Altaf A Lal; Bernard L Nahlen; Peter B Bloland; Kim A Lindblade; Vincent Were; Kephas Otieno; Peter Otieno; Chris Odero; Laurence Slutsker; John M Vulule; John E Gimnig
Journal:  Malar J       Date:  2014-11-22       Impact factor: 2.979

Review 4.  Research priorities for the development and implementation of serological tools for malaria surveillance.

Authors:  Salenna R Elliott; Freya J I Fowkes; Jack S Richards; Linda Reiling; Damien R Drew; James G Beeson
Journal:  F1000Prime Rep       Date:  2014-11-04

5.  Combined Use of Malaria Antigen and Antibody Enzyme-Linked Immunosorbent Assay for Blood Screening of Plasmodium vivax in the Republic of Korea.

Authors:  Jeeyong Kim; Jin Woo Jang; Ju Yeon Kim; Deok Ja Oh; Chae Seung Lim
Journal:  Med Princ Pract       Date:  2016-01-21       Impact factor: 1.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.